{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:10:11Z","timestamp":1781766611371,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.ejps.2013.10.016","type":"journal-article","created":{"date-parts":[[2013,11,9]],"date-time":"2013-11-09T02:46:07Z","timestamp":1383965167000},"page":"191-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate\/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery"],"prefix":"10.1016","volume":"52","author":[{"given":"Xiaojian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick G.","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Don","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi M.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2013.10.016_b0010","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1002\/jps.21195","article-title":"The influence of drug morphology on aerosolisation efficiency of dry powder inhaler formulations","volume":"97","author":"Adi","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.10.016_b0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejps.2008.05.009","article-title":"Micro-particle corrugation, adhesion and inhalation aerosol efficiency","volume":"35","author":"Adi","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.10.016_b0020","unstructured":"Burnett, D., Malde, N., Daryl, W., 2009. Characterizing Amorphous Materials with Gravimetric Vapour Sorption Techniques. Pharmaceutical Technology Europe."},{"key":"10.1016\/j.ejps.2013.10.016_b0025","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1023\/A:1015858503031","article-title":"Solid-state properties of tobramycin","volume":"8","author":"Dash","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2013.10.016_b0030","unstructured":"Finlay, W.H., 2008. The ARLA Respiratory Deposition Calculator."},{"key":"10.1016\/j.ejps.2013.10.016_b0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0928-0987(02)00087-8","article-title":"Characterization of azithromycin hydrates","volume":"16","author":"Gandhi","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.10.016_b0040","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0169-409X(02)00159-X","article-title":"Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy","volume":"54","author":"Garcia-Contreras","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2013.10.016_b0045","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1023\/A:1018941810744","article-title":"The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids","volume":"11","author":"Hancock","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2013.10.016_b0050","first-page":"182","article-title":"Aerosolized vancomycin for the treatment of MRSA after lung transplantation","volume":"15","author":"Hayes","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.ejps.2013.10.016_b0055","series-title":"Modified-Release Drug Delivery Technology","first-page":"573","article-title":"Formulation challenges of powders for the delivery of small molecular weight molecules as aerosols","author":"Hickey","year":"2008"},{"key":"10.1016\/j.ejps.2013.10.016_b0060","series-title":"Modern Pharmaceutics","first-page":"191","article-title":"Delivery of drugs by the pulmonary route","author":"Hickey","year":"2009"},{"key":"10.1016\/j.ejps.2013.10.016_b0065","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/jps.20916","article-title":"Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics","volume":"96","author":"Hickey","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.10.016_b0070","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/jps.20943","article-title":"Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics","volume":"96","author":"Hickey","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.10.016_b0075","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1208\/s12249-011-9704-0","article-title":"Physicochemical characterization and water vapor sorption of organic solution advanced spray-dried inhalable trehalose microparticles and nanoparticles for targeted dry powder pulmonary inhalation delivery","volume":"12","author":"Li","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2013.10.016_b0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0092-1157(82)80038-3","article-title":"The first international reference preparation of tobramycin","volume":"10","author":"Lightbown","year":"1982","journal-title":"J. Biol. Stand."},{"key":"10.1016\/j.ejps.2013.10.016_b0085","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1023\/B:PHAM.0000033007.27278.60","article-title":"Aerosol dispersion of respirable particles in narrow size distributions produced by jet-milling and spray-drying techniques","volume":"21","author":"Louey","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2013.10.016_b0090","doi-asserted-by":"crossref","unstructured":"Mansour, H.M., Hickey, A.J., 2007. Raman Characterization and Chemical Imaging of Biocolloidal Self-Assemblies, Drug Delivery Systems, and Pulmonary Inhalation Aerosols. A Review. AAPS PharmSciTech 8, Article 99 (E01\u2013E16).","DOI":"10.1208\/pt0804099"},{"key":"10.1016\/j.ejps.2013.10.016_b0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/jps.20810","article-title":"The relationship between water vapor absorption and desorption by phospholipids and bilayer phase transitions","volume":"96","author":"Mansour","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.10.016_b0095","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/IJN.S4937","article-title":"Nanomedicine in pulmonary delivery","volume":"4","author":"Mansour","year":"2009","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2013.10.016_b0105","first-page":"275","article-title":"Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable DPPC and DPPC:DPPE-PEG microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols","volume":"8","author":"Meenach","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2013.10.016_b0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2007.06.001","article-title":"Preparation of drug nanoparticle-containing microparticles using a 4-fluid nozzle spray drier for oral, pulmonary, and injection dosage forms","volume":"122","author":"Mizoe","year":"2007","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejps.2013.10.016_b0115","series-title":"Textbook of Respiratory Medicine","author":"Murray","year":"1988"},{"key":"10.1016\/j.ejps.2013.10.016_b0120","first-page":"32","article-title":"Pulmonary inhalation aerosols for targeted antibiotics delivery","volume":"16","author":"Park","year":"2011","journal-title":"Eur. Pharmaceut. Rev."},{"key":"10.1016\/j.ejps.2013.10.016_b0125","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.addr.2011.08.004","article-title":"Advances in microscopy and complementary imaging techniques to assess the fate of drugs ex-vivo in respiratory drug delivery. Invited paper","volume":"64","author":"Park","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2013.10.016_b0130","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.coph.2006.07.001","article-title":"Clinical experience with recently approved antibiotics","volume":"6","author":"Paterson","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejps.2013.10.016_b0135","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1592\/phco.25.4.555.61025","article-title":"Antiinflammatory therapies for cystic fibrosis: past, present, and future","volume":"25","author":"Prescott","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejps.2013.10.016_b0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/annhyg\/26.1.33","article-title":"Comparison of the criteria for sampling \u2018inhalable\u2019 and \u2018respirable\u2019 aerosols","volume":"26","author":"Raabe","year":"1982","journal-title":"Ann. Occup. Hyg."},{"key":"10.1016\/j.ejps.2013.10.016_b0145","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.healun.2004.08.006","article-title":"Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients","volume":"24","author":"Shitrit","year":"2005","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.ejps.2013.10.016_b0150","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1016\/S0924-8579(09)70004-4","article-title":"What\u2019s new on the antimicrobial horizon?","volume":"32","author":"Song","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejps.2013.10.016_b0155","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/15298668091424933","article-title":"Experimental determination of the regional deposition of aerosol particles in the human respiratory tract","volume":"41","author":"Stahlhofen","year":"1980","journal-title":"Am. Ind. Hyg. Assoc. J."},{"key":"10.1016\/j.ejps.2013.10.016_b0160","first-page":"652","article-title":"Drug properties affecting aerosol behavior","volume":"45","author":"Suarez","year":"2000","journal-title":"Respir. Care"},{"key":"10.1016\/j.ejps.2013.10.016_b0165","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/thx.47.6.426","article-title":"Extrapulmonary sites of Pseudomonas aeruginosa in adults with cystic fibrosis","volume":"47","author":"Taylor","year":"1992","journal-title":"Thorax"},{"key":"10.1016\/j.ejps.2013.10.016_b0005","unstructured":"The United States Pharmacopeial Convention Inc., 2006. <601> Aerosols, Nasal Sprays, Metered-Dose Inhalers, and Dry Powder Inhalers Monograph, USP 29-NF 24 the United States Pharmacopoeia and The National Formulary: The Official Compendia of Standards. The United States Pharmacopeial Convention Inc., Rockville, MD, pp. 2617\u20132636."},{"key":"10.1016\/j.ejps.2013.10.016_b0170","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ppul.10134","article-title":"Detecting early structural lung damage in cystic fibrosis","volume":"34","author":"Tiddens","year":"2002","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ejps.2013.10.016_b0175","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1164\/rccm.200410-1414OC","article-title":"Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size","volume":"172","author":"Usmani","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejps.2013.10.016_b0180","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1172\/JCI0213870","article-title":"Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients","volume":"109","author":"Worlitzsch","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2013.10.016_b0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14356\/kona.2010005","article-title":"Surface analytical techniques in solid-state particle characterization: implications for predicting performance in dry powder inhalers","author":"Wu","year":"2010","journal-title":"KONA Powder Part. J."},{"key":"10.1016\/j.ejps.2013.10.016_b0185","first-page":"59","article-title":"Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation","volume":"7","author":"Wu","year":"2013","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejps.2013.10.016_b0195","first-page":"1","article-title":"Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine a multifunctional particles for dry powder inhalation aerosol delivery","volume":"8","author":"Wu","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2013.10.016_b0205","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1002\/jps.22057","article-title":"Heterogeneous particle deaggregation and its implication for therapeutic aerosol performance","volume":"99","author":"Xu","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.10.016_b0200","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1163\/016942410X525669","article-title":"Particle interactions in dry powder inhaler unit processes","volume":"25","author":"Xu","year":"2011","journal-title":"J. Adhes. Sci. Technol.: Spec. Iss. Adhes. Asp. Pharmaceut. Sci."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098713004235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098713004235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T04:31:03Z","timestamp":1564633863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098713004235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":41,"alternative-id":["S0928098713004235"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2013.10.016","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate\/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2013.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}